The FDA grants de novo clearance to HeartFlow's novel system for non-invasive measurement of fractional flow reserve, which CEO Dr. John Stevens calls "the gold standard" for diagnosing and treating coronary disease.
Fall River, Mass.-based NuOrtho Surgical declares bankruptcy and looks to liquidate its remaining assets to pay of its creditors, who include several former executives.
After a 7-year run Fall River, Mass.-based NuOrtho Surgical filed for Chapter 7 bankruptcy, listing liabilities of $4.74 million and assets of $287,117. Nearly 40 patents were also cited in the filing, some of which had been used as collateral.
Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.
Law firm Greenberg Traurig, MassMEDIC and LB Ventures created Medtech Partnering Day with an eye on putting start-ups and medtech titans together in the same room.
Editors note: This article originally ran Jan. 21, but the event was postponed due to snow in the Boston area. Greenberg Traurig is slated to host the next MedTech Partnering Day March 13 in its Boston office. Contact email@example.com by March 11 to participate.
Regdy blog's Andrew Ahn discusses the advantages of getting your device approved by FDA.
Playing within the lines of non-medical wellness toys is fun, but lets get serious. If you want your product to be seriously meaningful with direct impact to saving lives through diagnosis and treatment, you should expand your medical technology into the world of medical devices and undergo the submission process with FDA. Here's why.